- ·The complete investor list: 17 names
- ·Watch Aprinoia Therapeutics: the Monday email on marks, rounds and moves
Aprinoia Therapeutics funding history
No funding rounds for Aprinoia Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Aprinoia Therapeutics valuation
Aprinoia Therapeutics's last known valuation is $295 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How Aprinoia Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Aprinoia Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Aprinoia Therapeutics
- What is Aprinoia Therapeutics worth?
- Aprinoia Therapeutics's last known valuation is $295.5M.
- How much has Aprinoia Therapeutics raised?
- Aprinoia Therapeutics has raised $65.0M in total funding across its recorded rounds.